Literature DB >> 26791754

Breast cancer-associated fibroblasts: their roles in tumor initiation, progression and clinical applications.

Aixiu Qiao1,2, Feng Gu1, Xiaojing Guo1, Xinmin Zhang3, Li Fu4.   

Abstract

Breast cancer is the most common malignant tumor in women, and the incidence of this disease has increased in recent years because of changes in diet, living environment, gestational age, and other unknown factors. Previous studies focused on cancer cells, but an increasing number of recent studies have analyzed the contribution of cancer microenvironment to the initiation and progression of breast cancer. Cancer-associated fibroblasts (CAFs), the most abundant cells in tumor stroma, secrete various active biomolecules, including extracellular matrix components, growth factors, cytokines, proteases, and hormones. CAFs not only facilitate the initiation, growth, angiogenesis, invasion, and metastasis of cancer but also serve as biomarkers in the clinical diagnosis, therapy, and prognosis of breast cancer. In this article, we reviewed the literature and summarized the research findings on CAFs in breast cancer.

Entities:  

Keywords:  breast cancer; cancer-associated fibroblast; prognosis; progression

Mesh:

Year:  2016        PMID: 26791754     DOI: 10.1007/s11684-016-0431-5

Source DB:  PubMed          Journal:  Front Med        ISSN: 2095-0217            Impact factor:   4.592


  100 in total

1.  Breast stroma plays a dominant regulatory role in breast epithelial growth and differentiation: implications for tumor development and progression.

Authors:  M P Shekhar; J Werdell; S J Santner; R J Pauley; L Tait
Journal:  Cancer Res       Date:  2001-02-15       Impact factor: 12.701

Review 2.  Prognostic relevance of cancer-associated fibroblasts in human cancer.

Authors:  Janna Paulsson; Patrick Micke
Journal:  Semin Cancer Biol       Date:  2014-02-19       Impact factor: 15.707

Review 3.  Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer.

Authors:  Roopali Roy; Jiang Yang; Marsha A Moses
Journal:  J Clin Oncol       Date:  2009-09-08       Impact factor: 44.544

4.  Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness.

Authors:  Elisa Giannoni; Francesca Bianchini; Lorenzo Masieri; Sergio Serni; Eugenio Torre; Lido Calorini; Paola Chiarugi
Journal:  Cancer Res       Date:  2010-08-10       Impact factor: 12.701

5.  Evidence for nonautonomous effect of p53 tumor suppressor in carcinogenesis.

Authors:  Hippokratis Kiaris; Ioulia Chatzistamou; George Trimis; Matrisa Frangou-Plemmenou; Agatha Pafiti-Kondi; Anastasios Kalofoutis
Journal:  Cancer Res       Date:  2005-03-01       Impact factor: 12.701

Review 6.  Role of oxidative stress and the microenvironment in breast cancer development and progression.

Authors:  Agnieszka Jezierska-Drutel; Steven A Rosenzweig; Carola A Neumann
Journal:  Adv Cancer Res       Date:  2013       Impact factor: 6.242

Review 7.  [Epithelial-mesenchymal transition in cancer progression].

Authors:  Monika Gos; Joanna Miłoszewska; Małgorzata Przybyszewska
Journal:  Postepy Biochem       Date:  2009

8.  Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells.

Authors:  Patsy S H Soon; Edward Kim; Cindy K Pon; Anthony J Gill; Katrina Moore; Andrew J Spillane; Diana E Benn; Robert C Baxter
Journal:  Endocr Relat Cancer       Date:  2013-01-07       Impact factor: 5.678

9.  Osteopontin mediates an MZF1-TGF-β1-dependent transformation of mesenchymal stem cells into cancer-associated fibroblasts in breast cancer.

Authors:  C E Weber; A N Kothari; P Y Wai; N Y Li; J Driver; M A C Zapf; C A Franzen; G N Gupta; C Osipo; A Zlobin; W K Syn; J Zhang; P C Kuo; Z Mi
Journal:  Oncogene       Date:  2014-12-22       Impact factor: 9.867

Review 10.  The role of endothelial-to-mesenchymal transition in cancer progression.

Authors:  S Potenta; E Zeisberg; R Kalluri
Journal:  Br J Cancer       Date:  2008-09-16       Impact factor: 7.640

View more
  27 in total

Review 1.  Lipid Metabolism in Tumor-Associated Fibroblasts.

Authors:  Hongzhong Li; Jingyuan Wan
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Targeting of sonic hedgehog-Gli signaling: A potential therapeutic target for patients with breast cancer.

Authors:  Lingqin Song; Weifeng Wang; Di Liu; Yang Zhao; Jianjun He; Xijing Wang; Zhijun Dai; Huimin Zhang; Xiao Li
Journal:  Oncol Lett       Date:  2016-06-15       Impact factor: 2.967

3.  Interleukin-6 receptor in spindle-shaped stromal cells, a prognostic determinant of early breast cancer.

Authors:  Vivian Labovsky; Leandro Marcelo Martinez; María de Luján Calcagno; Kevin Mauro Davies; Hernán García-Rivello; Alejandra Wernicke; Leonardo Feldman; María Belén Giorello; Ayelén Matas; Francisco Raúl Borzone; Scott C Howard; Norma Alejandra Chasseing
Journal:  Tumour Biol       Date:  2016-07-27

4.  Stromal-associated cytokines bias the interplay between gene expression and DNA methylation in human breast cancers.

Authors:  Hector Hernandez-Vargas; Chloe Goldsmith; Pauline Mathot; Robert Dante
Journal:  Epigenetics       Date:  2019-12-14       Impact factor: 4.528

Review 5.  MicroRNAs and Their Impact on Breast Cancer, the Tumor Microenvironment, and Disparities.

Authors:  A Evans-Knowell; A C LaRue; V J Findlay
Journal:  Adv Cancer Res       Date:  2016-09-26       Impact factor: 5.767

6.  Stromal Activation by Tumor Cells: An in Vitro Study in Breast Cancer.

Authors:  Giuseppe Merlino; Patrizia Miodini; Biagio Paolini; Maria Luisa Carcangiu; Massimiliano Gennaro; Matteo Dugo; Maria Grazia Daidone; Vera Cappelletti
Journal:  Microarrays (Basel)       Date:  2016-05-18

7.  Gene expression in local stroma reflects breast tumor states and predicts patient outcome.

Authors:  Russell Bainer; Casey Frankenberger; Daniel Rabe; Gary An; Yoav Gilad; Marsha Rich Rosner
Journal:  Sci Rep       Date:  2016-12-16       Impact factor: 4.379

8.  Estrogen-induced SDF-1α production promotes the progression of ER-negative breast cancer via the accumulation of MDSCs in the tumor microenvironment.

Authors:  Liquan Ouyang; Weilong Chang; Bin Fang; Jieting Qin; Xincai Qu; Fanjun Cheng
Journal:  Sci Rep       Date:  2016-12-20       Impact factor: 4.379

Review 9.  Cancer-Associated Fibroblasts in the Breast Tumor Microenvironment.

Authors:  María Belén Giorello; Francisco Raúl Borzone; Vivian Labovsky; Flavia Valeria Piccioni; Norma Alejandra Chasseing
Journal:  J Mammary Gland Biol Neoplasia       Date:  2021-01-04       Impact factor: 2.673

Review 10.  Crosstalk between Tumor-Infiltrating Immune Cells and Cancer-Associated Fibroblasts in Tumor Growth and Immunosuppression of Breast Cancer.

Authors:  Jarupa Soongsathitanon; Pranisa Jamjuntra; Nuttavut Sumransub; Supaporn Yangngam; Marjorie De la Fuente; Glauben Landskron; Peti Thuwajit; Marcela A Hermoso; Chanitra Thuwajit
Journal:  J Immunol Res       Date:  2021-07-13       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.